Nadia Harbeck

Nadia Harbeck

UNVERIFIED PROFILE

Are you Nadia Harbeck?   Register this Author

Register author
Nadia Harbeck

Nadia Harbeck

Publications by authors named "Nadia Harbeck"

Are you Nadia Harbeck?   Register this Author

100Publications

2438Reads

23Profile Views

A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application Development.

JMIR Public Health Surveill 2020 06 1;6(2):e19033. Epub 2020 Jun 1.

Department of Medicine III, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2196/19033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265653PMC
June 2020

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.

J Pathol 2020 Apr 9;250(5):667-684. Epub 2020 Apr 9.

Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5406DOI Listing
April 2020

Breast cancer is a systemic disease optimally treated by a multidisciplinary team.

Authors:
Nadia Harbeck

Nat Rev Dis Primers 2020 04 23;6(1):30. Epub 2020 Apr 23.

Breast Center, Department of Gynecology and Obstetrics and CCCLMU, University of Munich (LMU), Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41572-020-0167-zDOI Listing
April 2020

Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.

J Transl Med 2020 02 21;18(1):94. Epub 2020 Feb 21.

Breast Center, Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-020-02271-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035771PMC
February 2020

Pembrolizumab for Early Triple-Negative Breast Cancer.

N Engl J Med 2020 02;382(9):810-821

From Barts Cancer Institute, Queen Mary University of London, London (P.S.); International Oncology Bureau Institute of Oncology, Quirón Group, Madrid, and Vall d'Hebron Institute of Oncology, Barcelona (J.C.) - both in Spain; Yale School of Medicine, Yale Cancer Center, New Haven, CT (L.P.); Cedars-Sinai Medical Center, Los Angeles (H.M.); Kliniken Essen-Mitte, Essen (S.K.), the Institute of Pathology, Philipps-University Marburg and University of Marburg, Marburg (C.D.), the Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center Ludwig Maximilian University of Munich, University of Munich, Munich (N.H.), University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Region of Nuremberg, Erlangen (P.A.F.), and the Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin (M.U.) - all in Germany; the Department of Oncology-Pathology, Karolinska Institutet and Breast Cancer Center, Theme Cancer, Karolinska University Hospital, Solna, Sweden (J.B., T.F.); Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (Y.H.P.); Westmead Breast Cancer Institute, Westmead Hospital and the University of Sydney, Sydney (R.H.); Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan (M.T.); the Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal (F.C.); Merck, Kenilworth, NJ (L.J., V.K., J.Z., G.A.); the National Cancer Center Singapore, Duke-National University of Singapore Medical School, Singapore (R.D.); and Baylor University Medical Center, Texas Oncology and US Oncology, Dallas (J.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1910549DOI Listing
February 2020

Emerging strategies in neoadjuvant treatment of patients with HER2-positive early breast cancer.

Authors:
Nadia Harbeck

Breast 2019 Nov;48 Suppl 1:S97-S102

Breast Center, Dept. OB&GYN and CCC(LMU), University of Munich (LMU), Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0960-9776(19)31134-8DOI Listing
November 2019

Breast cancer.

Nat Rev Dis Primers 2019 09 23;5(1):66. Epub 2019 Sep 23.

Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41572-019-0111-2DOI Listing
September 2019

[Breast cancer - a modern approach in oncoplastic surgery].

MMW Fortschr Med 2019 Aug;161(14):47-50

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität München, Campus Innenstadt, Maistrasse 11, D-80337, München, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15006-019-0784-1DOI Listing
August 2019

[Breast cancer in young women].

MMW Fortschr Med 2019 Aug;161(14):43-47

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, München, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15006-019-0783-2DOI Listing
August 2019

Brustkrebs-Patientinnen brauchen auch Ihre Unterstützung!

MMW Fortschr Med 2019 Aug;161(14):42

Frauenklinik, Brustzentrum und CCCLMU der Ludwig-Maximilians-Universität München, München, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15006-019-0782-3DOI Listing
August 2019

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.

N Engl J Med 2019 07 4;381(4):307-316. Epub 2019 Jun 4.

From Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (S.-A.I.), the Yonsei Cancer Center, Yonsei University Health System (J.S.), and the Asan Medical Center, University of Ulsan College of Medicine (K.-H.J.), Seoul, and the Center for Breast Cancer, National Cancer Center, Gyeonggi-do (K.-S.L.) - all in South Korea; National Taiwan University Hospital, Taipei, Taiwan (Y.-S.L.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (A.B.); the Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, Munich, Germany (N.H.); the Division of Medical Senology, Istituto Europeo di Oncologia, Milan (M.C.); Hospital de Caridade de Ijuí, CACON, Ijuí, Brazil (F.F.); the Organisation for Oncology and Translational Research, Hong Kong (L.C.); Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico (S.C.-G.); Institut Català d'Oncologia, Hospital de Sant Joan Despí Moisès Broggi, Barcelona (R.V.-V.); Novartis Pharmaceuticals, East Hanover, NJ (A.C., K.R.-L., T.T.); Novartis, Basel, Switzerland (G.H., I.G.); the UCLA Jonsson Comprehensive Cancer Center, Los Angeles (S.H.); and the University of Texas M.D. Anderson Cancer Center, Houston (D.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903765DOI Listing
July 2019

Digitalization in Medicine: It Is Our Chance and Responsibility Now to Shape the Digital Future of Breast Cancer Management.

Authors:
Nadia Harbeck

Breast Care (Basel) 2019 Jun 3;14(3):128-129. Epub 2019 Jun 3.

Brustzentrum, Frauenklinik und CCCLMU der Universität München (LMU), Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000501185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600119PMC
June 2019

Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study.

Strahlenther Onkol 2019 Apr 25;195(4):289-296. Epub 2018 Jul 25.

Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-018-1337-8DOI Listing
April 2019

Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies.

Future Oncol 2019 Apr 5;15(12):1313-1322. Epub 2019 Mar 5.

Hexal AG, Holzkirchen 83607, Germany.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2018-0878
Publisher Site
http://dx.doi.org/10.2217/fon-2018-0878DOI Listing
April 2019

CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib.

BioDrugs 2019 Apr;33(2):125-135

Department of OB&GYN, Breast Center, University of Munich (LMU), Marchioninistrasse 15, 81377, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40259-019-00337-6DOI Listing
April 2019

St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.

Breast Care (Basel) 2019 Apr 4;14(2):103-110. Epub 2019 Apr 4.

Breast Center, Department of Obstetrics and Gynecology, University of Munich (LMU), Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000499931DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886108PMC
April 2019

Recover your smile: Effects of a beauty care intervention on depressive symptoms, quality of life, and self-esteem in patients with early breast cancer.

Psychooncology 2019 02 21;28(2):401-407. Epub 2018 Dec 21.

Division of Clinical Psychology, Psychotherapy, and Health Psychology, Department of Psychology, University of Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.4957DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590176PMC
February 2019

Truly personalized therapy - an end to the era of one size fits all.

Nat Rev Clin Oncol 2019 02;16(2):77-78

Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center (CCCLMU), University of Munich (LMU), Munich, Germany.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41571-018-0165-1
Publisher Site
http://dx.doi.org/10.1038/s41571-018-0165-1DOI Listing
February 2019

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.

Breast Cancer (Dove Med Press) 2019 19;11:87-97. Epub 2019 Feb 19.

Breast Center, Department of Gynecology and Obstetrics and CCC Munich, University of Munich (LMU), 81377 Munich, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BCTT.S178721DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385785PMC
February 2019

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.

N Engl J Med 2018 Nov 20;379(20):1926-1936. Epub 2018 Oct 20.

From the Institute of Cancer Research and Royal Marsden Hospital, London (N.C.T.); David Geffen School of Medicine at University of California, Los Angeles, Santa Monica (D.J.S.), and Pfizer Oncology, San Diego (X.H.) - both in California; National Cancer Center, Goyang-si, Gyeonggi-do (J.R.), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul (S.-A.I.) - both in South Korea; Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital 4, Dnipropetrovsk, Ukraine (I.B.); National Hospital Organization Osaka National Hospital, Osaka (N.M.), and Aichi Cancer Center Hospital, Nagoya (H.I.) - both in Japan; Istituto Europeo di Oncologia (M. Colleoni) and Pfizer Oncology (C.G.) - both in Milan; Abramson Cancer Center, University of Pennsylvania, Philadelphia (A.D.), and Pfizer Oncology, Collegeville (C.H.B.) - both in Pennsylvania; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi); Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada (S.V.); Brustzentrum der Universität München, Munich (N.H.), and the German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany; Institut Gustave Roussy, Villejuif, France (F.A.); Pfizer Oncology, Cambridge, MA (K.P.T.); and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago (M. Cristofanilli).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1810527
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1810527DOI Listing
November 2018

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.

Authors:
Achim Wöckel Jasmin Festl Tanja Stüber Katharina Brust Mathias Krockenberger Peter U Heuschmann Steffi Jírů-Hillmann Ute-Susann Albert Wilfried Budach Markus Follmann Wolfgang Janni Ina Kopp Rolf Kreienberg Thorsten Kühn Thomas Langer Monika Nothacker Anton Scharl Ingrid Schreer Hartmut Link Jutta Engel Tanja Fehm Joachim Weis Anja Welt Anke Steckelberg Petra Feyer Klaus König Andrea Hahne Traudl Baumgartner Hans H Kreipe Wolfram Trudo Knoefel Michael Denkinger Sara Brucker Diana Lüftner Christian Kubisch Christina Gerlach Annette Lebeau Friederike Siedentopf Cordula Petersen Hans Helge Bartsch Rüdiger Schulz-Wendtland Markus Hahn Volker Hanf Markus Müller-Schimpfle Ulla Henscher Renza Roncarati Alexander Katalinic Christoph Heitmann Christoph Honegger Kerstin Paradies Vesna Bjelic-Radisic Friedrich Degenhardt Frederik Wenz Oliver Rick Dieter Hölzel Matthias Zaiss Gudrun Kemper Volker Budach Carsten Denkert Bernd Gerber Hans Tesch Susanne Hirsmüller Hans-Peter Sinn Jürgen Dunst Karsten Münstedt Ulrich Bick Eva Fallenberg Reina Tholen Roswita Hung Freerk Baumann Matthias W Beckmann Jens Blohmer Peter Fasching Michael P Lux Nadia Harbeck Peyman Hadji Hans Hauner Sylvia Heywang-Köbrunner Jens Huober Jutta Hübner Christian Jackisch Sibylle Loibl Hans-Jürgen Lück Gunter von Minckwitz Volker Möbus Volkmar Müller Ute Nöthlings Marcus Schmidt Rita Schmutzler Andreas Schneeweiss Florian Schütz Elmar Stickeler Christoph Thomssen Michael Untch Simone Wesselmann Arno Bücker Andreas Buck Stephanie Stangl

Geburtshilfe Frauenheilkd 2018 Nov 26;78(11):1056-1088. Epub 2018 Nov 26.

Institut für Klinische Epidemiologie und Biometrie (IKE-B), Universität Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/a-0646-4630
Publisher Site
http://dx.doi.org/10.1055/a-0646-4630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261741PMC
November 2018

Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival.

Transl Oncol 2018 Oct 11;11(5):1090-1096. Epub 2018 Jul 11.

IRCM - Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université Montpellier, Parc Euromédecine, 208 rue des Apothicaires, F-34298 Montpellier Cedex 5, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2018.06.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070698PMC
October 2018

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer.

Geburtshilfe Frauenheilkd 2018 Oct 19;78(10):927-948. Epub 2018 Oct 19.

Universitätsfrauenklinik Würzburg, Universität Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/a-0646-4522
Publisher Site
http://dx.doi.org/10.1055/a-0646-4522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202580PMC
October 2018

Prognostic impact of residual disease in simultaneous additional excision specimens after one-step breast conserving therapy with negative final margin status in primary breast cancer.

Eur J Surg Oncol 2018 09 23;44(9):1318-1323. Epub 2018 Jun 23.

Department of Obstetrics and Gynecology, University Hospital, LMU Munich, 15, 81377 Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2018.06.014DOI Listing
September 2018

Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?

Authors:
Nadia Harbeck

Ther Adv Med Oncol 2018 11;10:1758835918782356. Epub 2018 Jul 11.

Breast Center, University of Munich (LMU), Marchioninistrasse 15, Munich, 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918782356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048618PMC
July 2018

Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients.

Breast Care (Basel) 2018 Apr 1;13(2):126-130. Epub 2018 Feb 1.

Breast Center, Department of Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University of Munich (LMU), Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000481340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981676PMC
April 2018

The safety of palbociclib for the treatment of advanced breast cancer.

Expert Opin Drug Saf 2018 Mar 28;17(3):325-330. Epub 2018 Jan 28.

a Breast Center, Department of Obstetrics and Gynecology , University Hospital, Ludwig-Maximilian-University Munich (LMU) , Munich , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2018.1429402DOI Listing
March 2018

Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology.

Arch Gynecol Obstet 2018 03 23;297(3):767-773. Epub 2018 Jan 23.

Department of Obstetrics and Gynecology, University Hospital Munich-Grosshadern, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00404-018-4681-0
Publisher Site
http://dx.doi.org/10.1007/s00404-018-4681-0DOI Listing
March 2018

ABC4 Consensus: Assessment by a German Group of Experts.

Breast Care (Basel) 2018 Mar 15;13(1):48-58. Epub 2018 Feb 15.

University Hospital and Polyclinic of Gynecology, Martin Luther University, Halle (Saale), Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000486722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016060PMC
March 2018

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling.

J Cancer Res Clin Oncol 2018 Feb 28;144(2):249-256. Epub 2017 Nov 28.

Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-017-2551-yDOI Listing
February 2018

Advances in targeting HER2-positive breast cancer.

Authors:
Nadia Harbeck

Curr Opin Obstet Gynecol 2018 Feb;30(1):55-59

Breast Center, Department of OB&GYN, University of Munich (LMU) Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GCO.0000000000000431DOI Listing
February 2018

Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines.

Drugs R D 2017 Dec;17(4):569-583

Department of Obstetrics and Gynecology, Breast Center, Ludwig-Maximilians University of Munich, Maistrasse 11, 80337, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40268-017-0208-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694421PMC
December 2017

[Breast cancer in male].

MMW Fortschr Med 2017 Dec;159(21-22):67-72

Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Brustzentrum und CCC, München, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15006-017-0395-7DOI Listing
December 2017

RE: Post-traumatic Stress as the Primary Cause for Cognitive Decline-Not the Whole Story, and Perhaps No Story at All.

J Natl Cancer Inst 2017 10;109(10)

Affiliations of authors: Breast Center, Department of Gynecology and Obstetrics, CCCLMU University Hospital of Munich, Munich, Germany (KH, SM, NH); Department of Psychology, Division of Psychological Methods and Assessment, Ludwig Maximilian University of Munich, Munich, Germany (MB); Department of Psychology, Division of Neuropsychology, Ludwig Maximilian University of Munich, Munich, Germany (KM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx147DOI Listing
October 2017

De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET.

J Clin Oncol 2017 Sep 6;35(26):3046-3054. Epub 2017 Jul 6.

Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.9815DOI Listing
September 2017

The safety and efficacy of palbociclib in the treatment of metastatic breast cancer.

Expert Rev Anticancer Ther 2017 08 12;17(8):661-668. Epub 2017 Jul 12.

b Breast Center, Department of Obstetrics and Gynecology , University of Munich (LMU) , Munich , Germany.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2017.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2017.1347506DOI Listing
August 2017

Neoadjuvant therapy for triple negative and HER2-positive early breast cancer.

Breast 2017 Aug 27;34 Suppl 1:S99-S103. Epub 2017 Jun 27.

West German Study Group, Moenchengladbach, Germany; Breast Center Niederrhein, Moenchengladbach, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2017.06.038DOI Listing
August 2017

Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.

Int J Mol Sci 2017 Jun 20;18(6). Epub 2017 Jun 20.

Department of Obstetrics and Gynaecology, Breast Center, Ludwig-Maximilians University of Munich (LMU), Maistrasse 11, Munich 80337, Germany.

View Article

Download full-text PDF

Source
http://www.mdpi.com/1422-0067/18/6/1318
Publisher Site
http://dx.doi.org/10.3390/ijms18061318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486139PMC
June 2017

St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment.

Breast Care (Basel) 2017 May 26;12(2):102-107. Epub 2017 Apr 26.

Department of Gynecology, Martin-Luther-University, Halle/Saale, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000475698DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447163PMC
May 2017